<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230907059376N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-10-22</date_registration>
      <primary_sponsor>Khyber Medical University, Peshawar</primary_sponsor>
      <public_title>Effectiveness of core stability exercises on energy expenditure during  gait in stroke patients; A randomized controlled trial</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of core stability exercises on energy expenditure during  gait in stroke patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-27</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>50</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/73267</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In our trial, randomization will be conducted using a lottery method. The unit of randomization is the individual participant. For each participant, a unique identifier will be assigned, and these identifiers will be placed in separate, opaque, and sealed envelopes. The envelopes will be thoroughly mixed before a neutral third party, who is not involved in the trial, draws an envelope for each participant. The treatment assignment corresponding to the label inside the drawn envelope will determine whether the participant receives core stability exercises or conventional physical therapy program. This method ensures the transparency and fairness of the allocation process, eliminating any potential for selection bias. Allocation concealment will be maintained throughout the trial, as the envelopes will be securely stored and opened only at the time of participant allocation, Blinding description: The Randomized Controlled Trial (RCT) registry is designed to ensure complete blinding of the outcome assessor, guaranteeing the integrity and impartiality of the study's results. By maintaining strict confidentiality protocols and employing a comprehensive masking system, the registry safeguards against any potential biases that may arise from the assessor's knowledge of the intervention groups, thereby enhancing the reliability and credibility of the trial's findings.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Brain stem stroke syndrome.</hc_freetext>
      <i_freetext>Intervention 1: Control group: The control group will receive the Modified Rehabilitation Program (MRP) for stroke patients three times a week, administered by trained physical therapists.The intensity of the MRP for the control group will be adjusted based on the patients' specific functional abilities, focusing on moderate-intensity exercises and activities to facilitate gradual recovery. Each session of the MRP for the control group will last for 30 minutes, ensuring an adequate duration to engage in a variety of tailored therapeutic exercises, functional tasks, and mobility training. The MRP for the control group will encompass a comprehensive range of evidence-based physical therapy techniques, including strength-building exercises, balance and coordination drills, as well as activities targeting range of motion and flexibility, tailored to the individualized needs of stroke patients. Intervention 2: Intervention group: Each participant in experimental group will have to attend a 6-weeks program of core stability exercises with 5 minutes each exercise, 5 days a week along with conventional physical therapy. Core stability exercises includes: 1. Bridging exercises 2. Unilateral pelvic bridging 3. Abdominal drawing in maneuver with leg lifts 4. Curl up.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Effectiveness of core stability exercises on energy expenditure during gait in stroke patients; A randomized controlled trial

When:
Data will be available after completion of RCT and will be available for 1 year

To whom:
To all the researchers, students and teachers.

Conditions:
All the authors registered with Iranian clinical trial registry

Where to obtain:
Data will be available by emailing the principal author on raheela.naz@rmi.edu.pk

How to obtain:
Just email the author

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Raheela Naz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5-B/2 Shaukat Khanum Rd, Phase 5 Hayatabad, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25000</zip>
        <telephone>+92 91 5838666</telephone>
        <email>raheela.naz@rmi.edu.pk</email>
        <affiliation>Rehman Medical Institute, Peshawar</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Raheela Naz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>5-B/2 Shaukat Khanum Rd, Phase 5 Hayatabad, Peshawar, Khyber Pakhtunkhwa</address>
        <city>Peshawar</city>
        <country1>Pakistan</country1>
        <zip>25000</zip>
        <telephone>+92 91 5838666</telephone>
        <email>raheela.naz@rmi.edu.pk</email>
        <affiliation>Rehman Medical Institute, Peshawar</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Stroke patients between 30 to 55 years of age
Both ischemic and hemorrhagic stroke
Patients who experienced a single stroke.
Patients who can walk for 10 minutes on ground at a comfortable speed(with or without assistive device)
Patients having MMSE score of 24 or more.</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>55 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients who has cerebellar and pontine stroke.
Patients who has orthopedic problems.
Patients who have vertigo, dizziness, angina or resting heart rate is not between 40-100bpm range.
Patients who cannot follow instructions given by the therapist</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>G46.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Brain stem stroke syndrome</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Control group: The control group will receive the Modified Rehabilitation Program (MRP) for stroke patients three times a week, administered by trained physical therapists.The intensity of the MRP for the control group will be adjusted based on the patients' specific functional abilities, focusing on moderate-intensity exercises and activities to facilitate gradual recovery. Each session of the MRP for the control group will last for 30 minutes, ensuring an adequate duration to engage in a variety of tailored therapeutic exercises, functional tasks, and mobility training. The MRP for the control group will encompass a comprehensive range of evidence-based physical therapy techniques, including strength-building exercises, balance and coordination drills, as well as activities targeting range of motion and flexibility, tailored to the individualized needs of stroke patients.</i_keyword>
      <i_keyword>Intervention group: Each participant in experimental group will have to attend a 6-weeks program of core stability exercises with 5 minutes each exercise, 5 days a week along with conventional physical therapy. Core stability exercises includes: 1. Bridging exercises 2. Unilateral pelvic bridging 3. Abdominal drawing in maneuver with leg lifts 4. Curl up.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Physiological cost index. Timepoint: Pre assessment will be done on baseline assessment and Post assessment will be done after 6 weeks. Method of measurement: Physiologic cost index(PCI) is an indicator of energy expenditure that includes heart rate during gait along with speed and the formula used will be energy expenditure: walking heart rate-resting heart rate/walking velocity.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Khyber Medical University, Peshawar</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-20</approval_date>
        <contact_name>KMU AS&amp;RB</contact_name>
        <contact_address>5-B/2 Shaukat Khanum Rd, Phase 5 Hayatabad, Peshawar, Khyber Pakhtunkhwa Peshawar Khyber Pakhtunkhwa Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
